insights_auto
Hvorfor er DRUG steget med 2,08%?
Dyk dybere nedchevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
74,55 CA$
arrow_upward
+2,08%(+1,52) 1D
19. okt., 16.00.00 GMT-4 · CAD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for DRUG...
Åbn
73,12 CA$
Høj
74,55 CA$
Lav
73,12 CA$
Markedsværdi
735,37 mio.
Gns. vol.
871,00
Volumen
330,00
Højeste i 52 uger
170,00 CA$
Laveste i 52 uger
68,02 CA$
Indtægt pr. aktie
-2,90 CA$
Antal ansatte
26
Åbn
73,12 CA$
Høj
74,55 CA$
Lav
73,12 CA$
Markedsværdi
735,37 mio.
Gns. vol.
871,00
Volumen
330,00
Højeste i 52 uger
170,00 CA$
Laveste i 52 uger
68,02 CA$
Indtægt pr. aktie
-2,90 CA$
Antal ansatte
26
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 1 dag siden
VIX-stigning i S&P 500-optioner betragtes som mindre, bemærker Robin Brooks
조선일보
·
for 19 minutter siden
Can South Korea Block Solidigm's Nasdaq Listing?
KuCoin
·
for 5 minutter siden
ABCD Fibonacci pattern identified at 10/20 00:00. This patte
Trefis
·
for 26 minutter siden
The 52-Week-Low List: 3 S&P 500 Names On Monday
Profil
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Om Bright Minds Biosciences Inc